BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25593461)

  • 1. Butein effects in colitis and interleukin-6/signal transducer and activator of transcription 3 expression.
    Lee SD; Choe JW; Lee BJ; Kang MH; Joo MK; Kim JH; Yeon JE; Park JJ; Kim JS; Bak YT
    World J Gastroenterol; 2015 Jan; 21(2):465-74. PubMed ID: 25593461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine suppresses acute colitis and colonic tumorigenesis associated with chronic colitis in mice.
    Hayashi S; Hamada T; Zaidi SF; Oshiro M; Lee J; Yamamoto T; Ishii Y; Sasahara M; Kadowaki M
    Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G968-78. PubMed ID: 25258409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irsogladine Maleate Prevents Colitis in Interleukin-10 Gene-Deficient Mice by Reducing Interleukin-12 and -23 Production.
    Nakagawa T; Katsuno T; Noguchi Y; Mandai Y; Yoshihama S; Saito K; Maruoka D; Matsumura T; Arai M; Yokosuka O
    Biol Pharm Bull; 2015; 38(11):1681-8. PubMed ID: 26521820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 induces S100A9 expression in colonic epithelial cells through STAT3 activation in experimental ulcerative colitis.
    Lee MJ; Lee JK; Choi JW; Lee CS; Sim JH; Cho CH; Lee KH; Cho IH; Chung MH; Kim HR; Ye SK
    PLoS One; 2012; 7(9):e38801. PubMed ID: 22962574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of adenosine A2B receptors ameliorates murine colitis.
    Kolachala V; Ruble B; Vijay-Kumar M; Wang L; Mwangi S; Figler H; Figler R; Srinivasan S; Gewirtz A; Linden J; Merlin D; Sitaraman S
    Br J Pharmacol; 2008 Sep; 155(1):127-37. PubMed ID: 18536750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombospondin peptide ABT-898 inhibits inflammation and angiogenesis in a colitis model.
    Gutierrez LS; Ling J; Nye D; Papathomas K; Dickinson C
    World J Gastroenterol; 2015 May; 21(20):6157-66. PubMed ID: 26034351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPR120, a potential therapeutic target for experimental colitis in IL-10 deficient mice.
    Zhao J; Wang H; Shi P; Wang W; Sun Y
    Oncotarget; 2017 Jan; 8(5):8397-8405. PubMed ID: 28039475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restraint stress induces and exacerbates intestinal inflammation in interleukin-10 deficient mice.
    Koh SJ; Kim JW; Kim BG; Lee KL; Kim JS
    World J Gastroenterol; 2015 Jul; 21(28):8580-7. PubMed ID: 26229400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis.
    Nighot P; Al-Sadi R; Rawat M; Guo S; Watterson DM; Ma T
    Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(12):G988-97. PubMed ID: 26514773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enalapril inhibits nuclear factor-κB signaling in intestinal epithelial cells and peritoneal macrophages and attenuates experimental colitis in mice.
    Lee C; Chun J; Hwang SW; Kang SJ; Im JP; Kim JS
    Life Sci; 2014 Jan; 95(1):29-39. PubMed ID: 24239644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butein impairs the protumorigenic activity of malignant pleural mesothelioma cells.
    Cioce M; Canino C; Pulito C; Muti P; Strano S; Blandino G
    Cell Cycle; 2012 Jan; 11(1):132-40. PubMed ID: 22185775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-γ and IL-17A regulate intestinal crypt production of CXCL10 in the healthy and inflamed colon.
    Walrath T; Malizia RA; Zhu X; Sharp SP; D'Souza SS; Lopez-Soler R; Parr B; Kartchner B; Lee EC; Stain SC; Iwakura Y; O'Connor W
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G479-G489. PubMed ID: 31790273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
    Yadav M; Huang MC; Goetzl EJ
    Cell Immunol; 2011; 267(2):124-32. PubMed ID: 21295288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embelin reduces colitis-associated tumorigenesis through limiting IL-6/STAT3 signaling.
    Dai Y; Jiao H; Teng G; Wang W; Zhang R; Wang Y; Hebbard L; George J; Qiao L
    Mol Cancer Ther; 2014 May; 13(5):1206-16. PubMed ID: 24651526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15-Lipoxygenase-1 suppression of colitis-associated colon cancer through inhibition of the IL-6/STAT3 signaling pathway.
    Mao F; Xu M; Zuo X; Yu J; Xu W; Moussalli MJ; Elias E; Li HS; Watowich SS; Shureiqi I
    FASEB J; 2015 Jun; 29(6):2359-70. PubMed ID: 25713055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory Actions of (+)-3'α-Angeloxy-4'-keto-3',4'-dihydroseselin (Pd-Ib) against Dextran Sulfate Sodium-Induced Colitis in C57BL/6 Mice.
    Mu HX; Liu J; Fatima S; Lin CY; Shi XK; Du B; Xiao HT; Fan BM; Bian ZX
    J Nat Prod; 2016 Apr; 79(4):1056-62. PubMed ID: 26905227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATF3 Sustains IL-22-Induced STAT3 Phosphorylation to Maintain Mucosal Immunity Through Inhibiting Phosphatases.
    Glal D; Sudhakar JN; Lu HH; Liu MC; Chiang HY; Liu YC; Cheng CF; Shui JW
    Front Immunol; 2018; 9():2522. PubMed ID: 30455690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brugia malayi cystatin therapeutically ameliorates dextran sulfate sodium-induced colitis in mice.
    Khatri V; Amdare N; Tarnekar A; Goswami K; Reddy MV
    J Dig Dis; 2015 Oct; 16(10):585-94. PubMed ID: 26358507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compartmentalized Response of IL-6/STAT3 Signaling in the Colonic Mucosa Mediates Colitis Development.
    Serrano C; Galán S; Rubio JF; Candelario-Martínez A; Montes-Gómez AE; Chánez-Paredes S; Cedillo-Barrón L; Schnoor M; Meraz-Ríos MA; Villegas-Sepúlveda N; Ortiz-Navarrete V; Nava P
    J Immunol; 2019 Feb; 202(4):1239-1249. PubMed ID: 30626693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.